This was an article pusblished at the University of Utah News and Public Relations. In a pair of new studies, University of Utah scientists took early but significant steps to fight a particularly deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors. The genetic events might be targets for new drugs that could be tested on the mice. Click here to read more.
Lee Siegel. Press Release 10/14/2004.
Thursday, October 14, 2004
Tuesday, June 1, 2004
GST Polymorphism relating to Childhood Cancer Risk
Phillip Barnette, Rebecca Scholl, Mary Blandford, Linda Ballard, Alexander Tsodikov, Jalene Magee, Susana Williams, Margaret Robertson, Francis Ali-Osman, Richard Lemons, Charles Keller. “High Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population,” Cancer Epidemiology, Biomarkers, and Prevention 2004; 13:304-313 [PubMed UID 14973099]
Sunday, February 15, 2004
Notes on the clinical care of Myofibrosarcoma
Charles Keller, Callie Gibbs, Steven Kelly, Jeffrey Haller, Keith White, Cheryl Coffin, Richard Lemons. “Low Grade Myofibrosarcoma of the Head and Neck: Importance of Early Referral and Surgical Therapy,” Journal of Pediatric Hematology-Oncology 2004; 26:119-120 [PubMed UID 14767203]
Tuesday, June 1, 1999
How small is too small: Growth Guidelines in Bloom Syndrome
Charles Keller, Kelly Keller, Stephen Shew, Sharon E. Plon. “Growth Deficiency and Malnutrition in Bloom Syndrome,” The Journal of Pediatrics 1999; 134:472-479 [PubMed UID 10190923]
Subscribe to:
Posts (Atom)